Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix von Struthers, R. Scott, Nicholls, Andrew J., Grundy, John, Chen, Takung, Jimenez, Roland, Yen, Samuel S. C., Bozigian, Haig P.

Volltext

Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine von Skor, Heather, Smith, Evan B., Loewen, Gordon, O’Brien, Christopher F., Grigoriadis, Dimitri E., Bozigian, Haig

Volltext

A pharmacokinetic evaluation of five H1 antagonists after an oral and intravenous microdose to human subjects von Madan, Ajay, O'Brien, Zhihong, Wen, Jianyun, O'Brien, Chris, Farber, Robert H., Beaton, Graham, Crowe, Paul, Oosterhuis, Berend, Garner, R. Colin, Lappin, Graham, Bozigian, Haig P.

Volltext

Suppression of Serum Luteinizing Hormone in Postmenopausal Women by an Orally Administered Nonpeptide Antagonist of the Gonadotropin-Releasing Hormone Receptor (NBI-42902) von Struthers, R. Scott, Chen, TaKung, Campbell, Bruce, Jimenez, Roland, Pan, Henry, Yen, Samuel S. C., Bozigian, Haig P.

Volltext

Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites von Grigoriadis, Dimitri E, Smith, Evan, Hoare, Sam R J, Madan, Ajay, Bozigian, Haig

Volltext

Pharmacological Characterization of a Novel Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor, NBI-42902 von Struthers, R. Scott, Xie, Qui, Sullivan, Susan K, Reinhart, Greg J, Kohout, Trudy A, Zhu, Yun-Fei, Chen, Chen, Liu, Xin-Jun, Ling, Nicholas, Yang, Weidong, Maki, Richard A, Bonneville, Anne K, Chen, Ta-Kung, Bozigian, Haig P

Volltext

Effect of Paroxetine on the Pharmacokinetics of Valbenazine and its Active Metabolite (9) von Smith, Evan, Loewen, Gordon, Luo, Rosa, Ingersoll, Shannon, Jimenez, Roland, Bozigian, Haig, Liang, Grace

Volltext

Effect of Once-Daily Opicapone on the Pharmacokinetics of Repaglinide (1654) von Loewen, Gordon, Liang, Grace, Jimenez, Roland, Olson, Kurt, Smith, Evan, Bozigian, Haig

Volltext

Pharmacologic Characteristics of Valbenazine (NBI-98854) and its Metabolites (P2.025) von Grigoriadis, Dimitri, Smith, Evan, Madan, Ajay, Wright, Clinton, Bozigian, Haig

Volltext

Design, Synthesis, In Vitro, and In Vivo Characterization of Phenylpiperazines and Pyridinylpiperazines as Potent and Selective Antagonists of the Melanocortin-4 Receptor von Tran, Joe A, Jiang, Wanlong, Tucci, Fabio C, Fleck, Beth A, Wen, Jenny, Sai, Yang, Madan, Ajay, Chen, Ta Kung, Markison, Stacy, Foster, Alan C, Hoare, Sam R, Marks, Daniel, Harman, John, Chen, Caroline W, Arellano, Melissa, Marinkovic, Dragan, Bozigian, Haig, Saunders, John, Chen, Chen

Volltext

Potent, Orally Active Corticotropin-Releasing Factor Receptor-1 Antagonists Containing a Tricyclic Pyrrolopyridine or Pyrazolopyridine Core von Dyck, Brian, Grigoriadis, Dimitri E, Gross, Raymond S, Guo, Zhiqiang, Haddach, Mustapha, Marinkovic, Dragan, McCarthy, James R, Moorjani, Manisha, Regan, Collin F, Saunders, John, Schwaebe, Michael K, Szabo, Tomas, Williams, John P, Zhang, Xiaohu, Bozigian, Haig, Chen, Ta Kung

Volltext

Suppression of Gonadotropins and Estradiol in Premenopausal Women by Oral Administration of the Nonpeptide Gonadotropin-Releasing Hormone Antagonist Elagolix von Struthers, R Scott, Nicholls, Andrew J, Grundy, John, Chen, Takung, Jimenez, Roland, Yen, Samuel S. C, Bozigian, Haig P

Volltext

Poster Number: NR 31 - Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group von Luo, Rosa, Jimenez, Roland, Loewen, Gordon, Bozigian, Haig, O'Brien, Christopher F.

Volltext

Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group von Luo, Rosa, Jimenez, Roland, Loewen, Gordon, Bozigian, Haig, O'Brien, Christopher F.

Volltext

Suppression of Serum Luteinizing Hormone in Postmenopausal Women by an Orally Administered Nonpeptide Antagonist of the Gonadotropin-Releasing Hormone Receptor (NBI-42902) von Struthers, R Scott, Chen, TaKung, Campbell, Bruce, Jimenez, Roland, Pan, Henry, Yen, Samuel S. C, Bozigian, Haig P

Volltext

Neuroprotective Effects of the CRF1 Antagonist R121920 after Permanent Focal Ischemia in the Rat von Mackay, Kenneth B., Bozigian, Haig, Grigoriadis, Dimitri E., Loddick, Sarah A., Verge, Gail, Foster, Alan C.

Volltext

Cardiac safety assessment of NBI-1: Potential role of I sub(Ks) potassium channel in the observed QT prolongation detected in vivo von Lio, Shirley, Bozigian, Haig

Volltext

Discovery of Sodium R-(+)-4-{2-[5-(2-Fluoro-3-methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (E... von Chen, Chen, Wu, Dongpei, Guo, Zhiqiang, Xie, Qiu, Reinhart, Greg J, Madan, Ajay, Wen, Jenny, Chen, Takung, Huang, Charles Q, Chen, Mi, Chen, Yongsheng, Tucci, Fabio C, Rowbottom, Martin, Pontillo, Joseph, Zhu, Yun-Fei, Wade, Warren, Saunders, John, Bozigian, Haig, Struthers, R. Scott

Volltext

A pharmacokinetic evaluation of five H 1 antagonists after an oral and intravenous microdose to human subjects von Madan, Ajay, O'Brien, Zhihong, Wen, Jianyun, O'Brien, Chris, Farber, Robert H., Beaton, Graham, Crowe, Paul, Oosterhuis, Berend, Garner, R. Colin, Lappin, Graham, Bozigian, Haig P.

Volltext

Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylamino-pyrazolo[1,5-a] pyrimidine (NBI 30775/r121919) and structure-activity relationships of a series of potent... von CHEN CHEN, WILCOXEN, Keith M, BOZIGIAN, Haig, GRIGORIADIS, Dimitri E, HUANG, Charles Q, XIE, Yun-Feng, MCCARTHY, James R, WEBB, Thomas R, ZHU, Yun-Fei, SAUNDERS, John, LIU, Xin-Jun, CHEN, Ta-Kung

Volltext